Pfizer Starts R&D in China After IPR in China Challenges

Photo Danny FriedmannPerilous hills, but nice view. Climb worth the risk? As one of the first U.S. companies pharmaceutical giant Pfizer has decided to start doing R&D in China. This way the company can probably take advantage of indigenous innovation preferential rules if it invents and patents in China. Read here. Pfizer had some IP […]